Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Eyegate Pharmaceuticals Inc.
EYEGV
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:EYEGV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 10:51am
KPRX .... N.H.O.D
Cheers to the Bulls
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 10:35am
KPRX ....when it's good news like ystrdy
It's good news Give it some time to get going again ; )
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 10:05am
KPRX .... Now it's rockin !!!
Yeehaaa
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 8:44am
KPRX .... stone cold !
Zero interest this a.m LoL
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 3:57pm
KPRX .... My prognostication is wrong...again ; )
C u 2morrow
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 2:45pm
KPRX..... I will take a stab and say KPRX will....
Make a N.H.O.D before the close today...currently at $4.68 GLTA
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 12:58pm
KPRX ....at resistance ?
Sold 1K shs.....nice big scalp Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 12:51pm
KPRX ....starting to rip again ; )
Heads up
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 12:31pm
KPRX ..... Don't quit on this....JMHO
The News is too good Kiora Pharmaceuticals Receives Investigational New Drug Approval for Phase 2 Study of KIO-101 for Treatment of Ocular Presentation
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 9:55am
KPRX ....needs a break of $5.70 with vol
And it will fly ....jmho
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 07, 2023 9:49am
KPRX ..... I was trying to buy some and post this
This could be 10 $'s in blink of an eye!!! No position....halted
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 03, 2023 7:01am
New Press Release - Kiora Pharmaceuticals Enters into Two Equity Purchase Agreements with Lincoln Park Capital
Encinitas, California--(Newsfile Corp. - February 3, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced that it has entered into a common stock purchase agreement for a committed equity financing (the "Purchase Agreement") with Lincoln Park Capital Fund,...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 09, 2023 7:01am
New Press Release - Kiora Pharmaceuticals Highlights Anticipated Clinical and Corporate Milestones for 2023; Webcast Now Available on Company Website
- Kiora is advancing a pipeline of therapeutics for rare and underserved ophthalmic diseases - - Anticipates reporting results in 1H 2023 from two clinical studies, one in patients with Retinitis Pigmentosa and another in patients with persistent corneal epithelial defects - - Expects to initiate...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 05, 2023 4:13pm
RE:KPRX...... I took my profit
Here is another call....wasn't wrong on this. I didn't post anything on it this a.m....but I did scalp it before I went skiing ; ) SH drops my reputation score..... what a joke !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 04, 2023 3:02pm
KPRX...... I took my profit
Suit yourself I have a mantra...... Take what the Market give you ; ) I'm sure this is going higher....ya never know !
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments